Table of Content

1 Report Overview
1.1 Huntington Disease Protein Definition
1.2 Market by Type
1.2.1 Global Huntington Disease Protein Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 NI-302
1.2.3 NLF-HD
1.2.4 P-301905
1.2.5 IONIS-HTTRx
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Huntington Disease Protein Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Alzheimer's Disease
1.3.3 Kennedy's Disease
1.3.4 Spinocerebellar Ataxia
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Huntington Disease Protein Sales
2.1 Global Huntington Disease Protein Revenue Estimates and Forecasts 2018-2034
2.2 Global Huntington Disease Protein Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Huntington Disease Protein Revenue by Region
2.3.1 Global Huntington Disease Protein Revenue by Region (2018-2023)
2.3.2 Global Huntington Disease Protein Revenue by Region (2024-2034)
2.4 Global Huntington Disease Protein Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Huntington Disease Protein Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Huntington Disease Protein Sales Quantity by Region
2.6.1 Global Huntington Disease Protein Sales Quantity by Region (2018-2023)
2.6.2 Global Huntington Disease Protein Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Huntington Disease Protein Sales Quantity by Manufacturers
3.1.1 Global Huntington Disease Protein Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Huntington Disease Protein Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Huntington Disease Protein Sales in 2024
3.2 Global Huntington Disease Protein Revenue by Manufacturers
3.2.1 Global Huntington Disease Protein Revenue by Manufacturers (2018-2023)
3.2.2 Global Huntington Disease Protein Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Huntington Disease Protein Revenue in 2024
3.3 Global Huntington Disease Protein Sales Price by Manufacturers
3.4 Global Key Players of Huntington Disease Protein, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Huntington Disease Protein, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Huntington Disease Protein, Product Offered and Application
3.8 Global Key Manufacturers of Huntington Disease Protein, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Huntington Disease Protein Sales Quantity by Type
4.1.1 Global Huntington Disease Protein Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Huntington Disease Protein Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Huntington Disease Protein Sales Quantity Market Share by Type (2018-2034)
4.2 Global Huntington Disease Protein Revenue by Type
4.2.1 Global Huntington Disease Protein Historical Revenue by Type (2018-2023)
4.2.2 Global Huntington Disease Protein Forecasted Revenue by Type (2024-2034)
4.2.3 Global Huntington Disease Protein Revenue Market Share by Type (2018-2034)
4.3 Global Huntington Disease Protein Price by Type
4.3.1 Global Huntington Disease Protein Price by Type (2018-2023)
4.3.2 Global Huntington Disease Protein Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Huntington Disease Protein Sales Quantity by Application
5.1.1 Global Huntington Disease Protein Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Huntington Disease Protein Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Huntington Disease Protein Sales Quantity Market Share by Application (2018-2034)
5.2 Global Huntington Disease Protein Revenue by Application
5.2.1 Global Huntington Disease Protein Historical Revenue by Application (2018-2023)
5.2.2 Global Huntington Disease Protein Forecasted Revenue by Application (2024-2034)
5.2.3 Global Huntington Disease Protein Revenue Market Share by Application (2018-2034)
5.3 Global Huntington Disease Protein Price by Application
5.3.1 Global Huntington Disease Protein Price by Application (2018-2023)
5.3.2 Global Huntington Disease Protein Price Forecast by Application (2024-2034)
6 North America
6.1 North America Huntington Disease Protein Sales by Company
6.1.1 North America Huntington Disease Protein Revenue by Company (2018-2023)
6.1.2 North America Huntington Disease Protein Sales Quantity by Company (2018-2023)
6.2 North America Huntington Disease Protein Market Size by Type
6.2.1 North America Huntington Disease Protein Sales Quantity by Type (2018-2034)
6.2.2 North America Huntington Disease Protein Revenue by Type (2018-2034)
6.3 North America Huntington Disease Protein Market Size by Application
6.3.1 North America Huntington Disease Protein Sales Quantity by Application (2018-2034)
6.3.2 North America Huntington Disease Protein Revenue by Application (2018-2034)
6.4 North America Huntington Disease Protein Market Size by Country
6.4.1 North America Huntington Disease Protein Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Huntington Disease Protein Revenue by Country (2018-2034)
6.4.3 North America Huntington Disease Protein Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Huntington Disease Protein Sales by Company
7.1.1 Europe Huntington Disease Protein Sales Quantity by Company (2018-2023)
7.1.2 Europe Huntington Disease Protein Revenue by Company (2018-2023)
7.2 Europe Huntington Disease Protein Market Size by Type
7.2.1 Europe Huntington Disease Protein Sales Quantity by Type (2018-2034)
7.2.2 Europe Huntington Disease Protein Revenue by Type (2018-2034)
7.3 Europe Huntington Disease Protein Market Size by Application
7.3.1 Europe Huntington Disease Protein Sales Quantity by Application (2018-2034)
7.3.2 Europe Huntington Disease Protein Revenue by Application (2018-2034)
7.4 Europe Huntington Disease Protein Market Size by Country
7.4.1 Europe Huntington Disease Protein Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Huntington Disease Protein Revenue by Country (2018-2034)
7.4.3 Europe Huntington Disease Protein Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Huntington Disease Protein Sales by Company
8.1.1 China Huntington Disease Protein Sales Quantity by Company (2018-2023)
8.1.2 China Huntington Disease Protein Revenue by Company (2018-2023)
8.2 China Huntington Disease Protein Market Size by Type
8.2.1 China Huntington Disease Protein Sales Quantity by Type (2018-2034)
8.2.2 China Huntington Disease Protein Revenue by Type (2018-2034)
8.3 China Huntington Disease Protein Market Size by Application
8.3.1 China Huntington Disease Protein Sales Quantity by Application (2018-2034)
8.3.2 China Huntington Disease Protein Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Huntington Disease Protein Sales by Company
9.1.1 APAC Huntington Disease Protein Sales Quantity by Company (2018-2023)
9.1.2 APAC Huntington Disease Protein Revenue by Company (2018-2023)
9.2 APAC Huntington Disease Protein Market Size by Type
9.2.1 APAC Huntington Disease Protein Sales Quantity by Type (2018-2034)
9.2.2 APAC Huntington Disease Protein Revenue by Type (2018-2034)
9.3 APAC Huntington Disease Protein Market Size by Application
9.3.1 APAC Huntington Disease Protein Sales Quantity by Application (2018-2034)
9.3.2 APAC Huntington Disease Protein Revenue by Application (2018-2034)
9.4 APAC Huntington Disease Protein Market Size by Region
9.4.1 APAC Huntington Disease Protein Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Huntington Disease Protein Revenue by Region (2018-2034)
9.4.3 APAC Huntington Disease Protein Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Huntington Disease Protein Sales by Company
10.1.1 Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Huntington Disease Protein Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Huntington Disease Protein Market Size by Type
10.2.1 Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Huntington Disease Protein Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Huntington Disease Protein Market Size by Application
10.3.1 Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Huntington Disease Protein Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Huntington Disease Protein Market Size by Country
10.4.1 Middle East, Africa and Latin America Huntington Disease Protein Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Huntington Disease Protein Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 AFFiRiS AG
11.1.1 AFFiRiS AG Company Information
11.1.2 AFFiRiS AG Overview
11.1.3 AFFiRiS AG Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 AFFiRiS AG Huntington Disease Protein Products and Services
11.1.5 AFFiRiS AG Huntington Disease Protein SWOT Analysis
11.1.6 AFFiRiS AG Recent Developments
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Company Information
11.2.2 Ionis Pharmaceuticals, Inc. Overview
11.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Products and Services
11.2.5 Ionis Pharmaceuticals, Inc. Huntington Disease Protein SWOT Analysis
11.2.6 Ionis Pharmaceuticals, Inc. Recent Developments
11.3 Neurimmune Holding AG
11.3.1 Neurimmune Holding AG Company Information
11.3.2 Neurimmune Holding AG Overview
11.3.3 Neurimmune Holding AG Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Neurimmune Holding AG Huntington Disease Protein Products and Services
11.3.5 Neurimmune Holding AG Huntington Disease Protein SWOT Analysis
11.3.6 Neurimmune Holding AG Recent Developments
11.4 nLife Therapeutics, S.L.
11.4.1 nLife Therapeutics, S.L. Company Information
11.4.2 nLife Therapeutics, S.L. Overview
11.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Products and Services
11.4.5 nLife Therapeutics, S.L. Huntington Disease Protein SWOT Analysis
11.4.6 nLife Therapeutics, S.L. Recent Developments
11.5 reMYND NV
11.5.1 reMYND NV Company Information
11.5.2 reMYND NV Overview
11.5.3 reMYND NV Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 reMYND NV Huntington Disease Protein Products and Services
11.5.5 reMYND NV Huntington Disease Protein SWOT Analysis
11.5.6 reMYND NV Recent Developments
11.6 Sangamo BioSciences, Inc.
11.6.1 Sangamo BioSciences, Inc. Company Information
11.6.2 Sangamo BioSciences, Inc. Overview
11.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Products and Services
11.6.5 Sangamo BioSciences, Inc. Huntington Disease Protein SWOT Analysis
11.6.6 Sangamo BioSciences, Inc. Recent Developments
11.7 UniQure N.V.
11.7.1 UniQure N.V. Company Information
11.7.2 UniQure N.V. Overview
11.7.3 UniQure N.V. Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 UniQure N.V. Huntington Disease Protein Products and Services
11.7.5 UniQure N.V. Huntington Disease Protein SWOT Analysis
11.7.6 UniQure N.V. Recent Developments
11.8 Voyager Therapeutics, Inc.
11.8.1 Voyager Therapeutics, Inc. Company Information
11.8.2 Voyager Therapeutics, Inc. Overview
11.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Products and Services
11.8.5 Voyager Therapeutics, Inc. Huntington Disease Protein SWOT Analysis
11.8.6 Voyager Therapeutics, Inc. Recent Developments
11.9 Vybion, Inc.
11.9.1 Vybion, Inc. Company Information
11.9.2 Vybion, Inc. Overview
11.9.3 Vybion, Inc. Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Vybion, Inc. Huntington Disease Protein Products and Services
11.9.5 Vybion, Inc. Huntington Disease Protein SWOT Analysis
11.9.6 Vybion, Inc. Recent Developments
11.10 WAVE Life Sciences Ltd.
11.10.1 WAVE Life Sciences Ltd. Company Information
11.10.2 WAVE Life Sciences Ltd. Overview
11.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Products and Services
11.10.5 WAVE Life Sciences Ltd. Huntington Disease Protein SWOT Analysis
11.10.6 WAVE Life Sciences Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Huntington Disease Protein Value Chain Analysis
12.2 Huntington Disease Protein Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Huntington Disease Protein Production Mode & Process
12.4 Huntington Disease Protein Sales and Marketing
12.4.1 Huntington Disease Protein Sales Channels
12.4.2 Huntington Disease Protein Distributors
12.5 Huntington Disease Protein Customers
13 Market Dynamics
13.1 Huntington Disease Protein Industry Trends
13.2 Huntington Disease Protein Market Drivers
13.3 Huntington Disease Protein Market Challenges
13.4 Huntington Disease Protein Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Huntington Disease Protein Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of NI-302
Table 3. Major Manufacturers of NLF-HD
Table 4. Major Manufacturers of P-301905
Table 5. Major Manufacturers of IONIS-HTTRx
Table 6. Major Manufacturers of Others
Table 7. Global Huntington Disease Protein Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Huntington Disease Protein Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Huntington Disease Protein Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Huntington Disease Protein Revenue Market Share by Region (2018-2023)
Table 11. Global Huntington Disease Protein Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Huntington Disease Protein Revenue Market Share by Region (2024-2034)
Table 13. Global Huntington Disease Protein Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Huntington Disease Protein Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Huntington Disease Protein Sales Market Share by Region (2018-2023)
Table 16. Global Huntington Disease Protein Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Huntington Disease Protein Sales Market Share by Region (2024-2034)
Table 18. Global Huntington Disease Protein Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Huntington Disease Protein Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Huntington Disease Protein Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Huntington Disease Protein Revenue Share by Manufacturers (2018-2023)
Table 22. Global Huntington Disease Protein Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Huntington Disease Protein, Industry Ranking, 2021 VS 2024
Table 24. Global Huntington Disease Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Huntington Disease Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Huntington Disease Protein as of 2024)
Table 26. Global Key Manufacturers of Huntington Disease Protein, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Huntington Disease Protein, Product Offered and Application
Table 28. Global Key Manufacturers of Huntington Disease Protein, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Huntington Disease Protein Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Huntington Disease Protein Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Huntington Disease Protein Sales Quantity Share by Type (2018-2023)
Table 33. Global Huntington Disease Protein Sales Quantity Share by Type (2024-2034)
Table 34. Global Huntington Disease Protein Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Huntington Disease Protein Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Huntington Disease Protein Revenue Share by Type (2018-2023)
Table 37. Global Huntington Disease Protein Revenue Share by Type (2024-2034)
Table 38. Huntington Disease Protein Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Huntington Disease Protein Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Huntington Disease Protein Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Huntington Disease Protein Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Huntington Disease Protein Sales Quantity Share by Application (2018-2023)
Table 43. Global Huntington Disease Protein Sales Quantity Share by Application (2024-2034)
Table 44. Global Huntington Disease Protein Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Huntington Disease Protein Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Huntington Disease Protein Revenue Share by Application (2018-2023)
Table 47. Global Huntington Disease Protein Revenue Share by Application (2024-2034)
Table 48. Huntington Disease Protein Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Huntington Disease Protein Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Huntington Disease Protein Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Huntington Disease Protein Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Huntington Disease Protein Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Huntington Disease Protein Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Huntington Disease Protein Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Huntington Disease Protein Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Huntington Disease Protein Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Huntington Disease Protein Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Huntington Disease Protein Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Huntington Disease Protein Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Huntington Disease Protein Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Huntington Disease Protein Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Huntington Disease Protein Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Huntington Disease Protein Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Huntington Disease Protein Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Huntington Disease Protein Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Huntington Disease Protein Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Huntington Disease Protein Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Huntington Disease Protein Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Huntington Disease Protein Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Huntington Disease Protein Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Huntington Disease Protein Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Huntington Disease Protein Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Huntington Disease Protein Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Huntington Disease Protein Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Huntington Disease Protein Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Huntington Disease Protein Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Huntington Disease Protein Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Huntington Disease Protein Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Huntington Disease Protein Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Huntington Disease Protein Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Huntington Disease Protein Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Huntington Disease Protein Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Huntington Disease Protein Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Huntington Disease Protein Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Huntington Disease Protein Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Huntington Disease Protein Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Huntington Disease Protein Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Huntington Disease Protein Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Huntington Disease Protein Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Huntington Disease Protein Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Huntington Disease Protein Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Huntington Disease Protein Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Huntington Disease Protein Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Huntington Disease Protein Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Huntington Disease Protein Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Huntington Disease Protein Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Huntington Disease Protein Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Huntington Disease Protein Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Huntington Disease Protein Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Huntington Disease Protein Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Huntington Disease Protein Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Huntington Disease Protein Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Huntington Disease Protein Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Huntington Disease Protein Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Huntington Disease Protein Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. AFFiRiS AG Company Information
Table 121. AFFiRiS AG Description and Overview
Table 122. AFFiRiS AG Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. AFFiRiS AG Huntington Disease Protein Product and Services
Table 124. AFFiRiS AG Huntington Disease Protein SWOT Analysis
Table 125. AFFiRiS AG Recent Developments
Table 126. Ionis Pharmaceuticals, Inc. Company Information
Table 127. Ionis Pharmaceuticals, Inc. Description and Overview
Table 128. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product and Services
Table 130. Ionis Pharmaceuticals, Inc. Huntington Disease Protein SWOT Analysis
Table 131. Ionis Pharmaceuticals, Inc. Recent Developments
Table 132. Neurimmune Holding AG Company Information
Table 133. Neurimmune Holding AG Description and Overview
Table 134. Neurimmune Holding AG Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Neurimmune Holding AG Huntington Disease Protein Product and Services
Table 136. Neurimmune Holding AG Huntington Disease Protein SWOT Analysis
Table 137. Neurimmune Holding AG Recent Developments
Table 138. nLife Therapeutics, S.L. Company Information
Table 139. nLife Therapeutics, S.L. Description and Overview
Table 140. nLife Therapeutics, S.L. Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. nLife Therapeutics, S.L. Huntington Disease Protein Product and Services
Table 142. nLife Therapeutics, S.L. Huntington Disease Protein SWOT Analysis
Table 143. nLife Therapeutics, S.L. Recent Developments
Table 144. reMYND NV Company Information
Table 145. reMYND NV Description and Overview
Table 146. reMYND NV Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. reMYND NV Huntington Disease Protein Product and Services
Table 148. reMYND NV Huntington Disease Protein SWOT Analysis
Table 149. reMYND NV Recent Developments
Table 150. Sangamo BioSciences, Inc. Company Information
Table 151. Sangamo BioSciences, Inc. Description and Overview
Table 152. Sangamo BioSciences, Inc. Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Sangamo BioSciences, Inc. Huntington Disease Protein Product and Services
Table 154. Sangamo BioSciences, Inc. Huntington Disease Protein SWOT Analysis
Table 155. Sangamo BioSciences, Inc. Recent Developments
Table 156. UniQure N.V. Company Information
Table 157. UniQure N.V. Description and Overview
Table 158. UniQure N.V. Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 159. UniQure N.V. Huntington Disease Protein Product and Services
Table 160. UniQure N.V. Huntington Disease Protein SWOT Analysis
Table 161. UniQure N.V. Recent Developments
Table 162. Voyager Therapeutics, Inc. Company Information
Table 163. Voyager Therapeutics, Inc. Description and Overview
Table 164. Voyager Therapeutics, Inc. Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 165. Voyager Therapeutics, Inc. Huntington Disease Protein Product and Services
Table 166. Voyager Therapeutics, Inc. Huntington Disease Protein SWOT Analysis
Table 167. Voyager Therapeutics, Inc. Recent Developments
Table 168. Vybion, Inc. Company Information
Table 169. Vybion, Inc. Description and Overview
Table 170. Vybion, Inc. Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 171. Vybion, Inc. Huntington Disease Protein Product and Services
Table 172. Vybion, Inc. Huntington Disease Protein SWOT Analysis
Table 173. Vybion, Inc. Recent Developments
Table 174. WAVE Life Sciences Ltd. Company Information
Table 175. WAVE Life Sciences Ltd. Description and Overview
Table 176. WAVE Life Sciences Ltd. Huntington Disease Protein Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 177. WAVE Life Sciences Ltd. Huntington Disease Protein Product and Services
Table 178. WAVE Life Sciences Ltd. Huntington Disease Protein SWOT Analysis
Table 179. WAVE Life Sciences Ltd. Recent Developments
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Huntington Disease Protein Distributors List
Table 183. Huntington Disease Protein Customers List
Table 184. Huntington Disease Protein Market Trends
Table 185. Huntington Disease Protein Market Drivers
Table 186. Huntington Disease Protein Market Challenges
Table 187. Huntington Disease Protein Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington Disease Protein Product Picture
Figure 2. Global Huntington Disease Protein Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Huntington Disease Protein Market Share by Type in 2024 & 2034
Figure 4. NI-302 Product Picture
Figure 5. NLF-HD Product Picture
Figure 6. P-301905 Product Picture
Figure 7. IONIS-HTTRx Product Picture
Figure 8. Others Product Picture
Figure 9. Global Huntington Disease Protein Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Huntington Disease Protein Market Share by Application in 2024 & 2034
Figure 11. Alzheimer's Disease
Figure 12. Kennedy's Disease
Figure 13. Spinocerebellar Ataxia
Figure 14. Others
Figure 15. Huntington Disease Protein Report Years Considered
Figure 16. Global Huntington Disease Protein Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Huntington Disease Protein Revenue 2018-2034 (US$ Million)
Figure 18. Global Huntington Disease Protein Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Huntington Disease Protein Sales Quantity 2018-2034 (K Pcs)
Figure 20. Global Huntington Disease Protein Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global Huntington Disease Protein Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Huntington Disease Protein Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. North America Huntington Disease Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Huntington Disease Protein Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. Europe Huntington Disease Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Huntington Disease Protein Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. China Huntington Disease Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Huntington Disease Protein Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. APAC Huntington Disease Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. Middle East, Africa and Latin America Huntington Disease Protein Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Huntington Disease Protein Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by Huntington Disease Protein Revenue in 2024
Figure 34. Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Huntington Disease Protein Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Huntington Disease Protein Revenue Market Share by Type (2018-2034)
Figure 37. Global Huntington Disease Protein Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Huntington Disease Protein Revenue Market Share by Application (2018-2034)
Figure 39. North America Huntington Disease Protein Revenue Market Share by Company in 2024
Figure 40. North America Huntington Disease Protein Sales Quantity Market Share by Company in 2024
Figure 41. North America Huntington Disease Protein Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Huntington Disease Protein Revenue Market Share by Type (2018-2034)
Figure 43. North America Huntington Disease Protein Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Huntington Disease Protein Revenue Market Share by Application (2018-2034)
Figure 45. North America Huntington Disease Protein Revenue Share by Country (2018-2034)
Figure 46. North America Huntington Disease Protein Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Huntington Disease Protein Sales Quantity Market Share by Company in 2024
Figure 50. Europe Huntington Disease Protein Revenue Market Share by Company in 2024
Figure 51. Europe Huntington Disease Protein Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Huntington Disease Protein Revenue Market Share by Type (2018-2034)
Figure 53. Europe Huntington Disease Protein Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Huntington Disease Protein Revenue Market Share by Application (2018-2034)
Figure 55. Europe Huntington Disease Protein Revenue Share by Country (2018-2034)
Figure 56. Europe Huntington Disease Protein Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 58. France Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 62. China Huntington Disease Protein Sales Quantity Market Share by Company in 2024
Figure 63. China Huntington Disease Protein Revenue Market Share by Company in 2024
Figure 64. China Huntington Disease Protein Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Huntington Disease Protein Revenue Market Share by Type (2018-2034)
Figure 66. China Huntington Disease Protein Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Huntington Disease Protein Revenue Market Share by Application (2018-2034)
Figure 68. APAC Huntington Disease Protein Sales Quantity Market Share by Company in 2024
Figure 69. APAC Huntington Disease Protein Revenue Market Share by Company in 2024
Figure 70. APAC Huntington Disease Protein Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Huntington Disease Protein Revenue Market Share by Type (2018-2034)
Figure 72. APAC Huntington Disease Protein Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Huntington Disease Protein Revenue Market Share by Application (2018-2034)
Figure 74. APAC Huntington Disease Protein Revenue Share by Region (2018-2034)
Figure 75. APAC Huntington Disease Protein Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 80. India Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Huntington Disease Protein Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Huntington Disease Protein Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Huntington Disease Protein Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Huntington Disease Protein Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Huntington Disease Protein Revenue Share by Country (2018-2034)
Figure 89. Brazil Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Huntington Disease Protein Revenue (2018-2034) & (US$ Million)
Figure 94. Huntington Disease Protein Value Chain
Figure 95. Huntington Disease Protein Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed